Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Substance user MMPI-2 profiles: predicting failure in completing treatment

L L Marshall1, R J Roiger

  • 1Chemical Dependency Studies, Mankato State University, Minnesota 56002, USA.

Substance Use & Misuse
|January 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The treatment of back pain by spinal mobilization.

The Australian journal of physiotherapy·2014
Same author

PTSD symptoms and partner abuse: low income women at risk.

Journal of traumatic stress·2001
Same author

Effects of men's subtle and overt psychological abuse on low-income women.

Violence and victims·1999
Same author

Distress and symptoms of posttraumatic stress disorder in abused women.

Violence and victims·1995
Same author

Infant formula products.

American pharmacy·1993
Same author

Students' experience in a phase III clinical trial.

American journal of hospital pharmacy·1990

This study used the Minnesota Multiphasic Personality Inventory-2 (MMPI-2) to predict treatment completion in chemically dependent patients. Neurotic patients and those with elevated scores on Scales 7 and 8 were more likely to not complete treatment.

Area of Science:

  • Psychology
  • Addiction Medicine
  • Clinical Psychology

Background:

  • Identifying patients likely to discontinue substance abuse treatment is crucial for optimizing resource allocation and patient outcomes.
  • The Minnesota Multiphasic Personality Inventory-2 (MMPI-2) is a widely used psychometric tool for assessing personality characteristics.

Purpose of the Study:

  • To develop a predictive model using MMPI-2 data to identify chemically dependent patients at high risk of treatment noncompletion.
  • To investigate the relationship between specific MMPI-2 profile types and treatment outcome in a chemically dependent population.

Main Methods:

  • Analysis of MMPI-2 profiles from 173 chemically dependent patients (142 male).
  • Utilized profile code types and multiple analysis of variance (MANOVA) for data analysis.

Related Experiment Videos

  • Chi-square tests were employed to assess categorical relationships.

    • Main Results:

    • Patients classified as neurotic demonstrated a higher likelihood of treatment failure (chi-square analysis).
    • Elevated T-scores on MMPI-2 Scales 7 (Psychasthenia) and 8 (Schizophrenia) were significantly associated with treatment noncompletion (MANOVA, p < .05).

    Conclusions:

    • Specific MMPI-2 characteristics, particularly neuroticism and elevated scores on Scales 7 and 8, can indicate a higher risk of treatment noncompletion.
    • The findings suggest that while MMPI-2 provides valuable insights, relying on a single objective measure may be insufficient for comprehensive outcome prediction in addiction treatment.